Cancer Research UK is investing £15 million into three newly-designated ‘major’ research centres in England to accelerate work in personalised cancer medicine and early detection of the disease.

CR UK centres in Oxford, Manchester Centre and Cambridge are the first to gain Major Centre status in the charity’s network of 15 research centres around the country, acting as vital research hubs “drawing together expertise, encouraging collaborative research, and bridging the gap between innovative laboratory work and benefits for patients,” the charity said.

With help from a cash injection of £5 million each, CR UK Oxford Centre is working on making treatments less invasive and more tailored to individual patients, the CR UK Manchester Centre plans to develop new techniques in personalised medicine, and the CR UK Cambridge Centre aims to create novel practical applications that will improve the detection and treatment of cancer. 

Iain Foulkes, executive director for research funding at Cancer Research UK, said the development of these Major Centres “will accelerate national and international collaborations and improve treatments for patients”.